Titan Medical, a medical technology company, agreed to acquire Conavi Medical, a commercial-stage medical device company, for $70m. "This merger is the result of a thoughtful and careful review of strategic options and reflects the continued commitment of our management team and Board of Directors to deliver value to shareholders. Conavi is an exciting commercial-stage company with groundbreaking technology and an accomplished management team. We are confident in their ability to continue to drive adoption of the Novasight Hybrid System," Paul Cataford, Titan Interim CEO and Board Chair.